The Edge

The U.S. Food and Drug Administration (FDA) recently approved Gilead’s antiviral Remdesivir for emergency use authorization (EUA) as a treatment ...

On April 21, Netflix reported exceedingly better-than-expected net new subscribers in their fiscal 1Q20 as COVID-19 induced lockdowns confined ...

A Global Meta-Analysis of Investment Research Analyst Forecasts While the world reels from the social and ...

Earnings season is here, and companies are expected to update full-year guidance to reflect the impact of the COVID-19 crisis. As events have ...

For both Nike and Adidas, the Greater China market is a strategically important growth driver, but after both companies provided updates on how ...

Analysts significantly lowered Uber’s bookings growth estimates after the company provided an update on March 19 on the impact of the COVID-19 ...

Questionable Profits Zillow analysts have widely different views on the company’s future profitability as they ...

Disney+ Subscriptions Revised Higher The launch of Disney+ has exceeded most analyst expectations after ending its ...

Analysts are expecting ridesharing companies Uber & Lyft to achieve profitability on an adjusted EBITDA basis sooner than previously ...

Our Vice President of Sales and Client Development, Barbara Lee, spoke on the “Defining Best Practice in Research Procurement” panel at